Pancreatic cancer is ready for investigation with a liquid biopsy, as indicated by analysts at The University of Texas MD Anderson Cancer Center52. A liquid biopsy is the simple, cheaper and faster, minimally invasive sampling and analysis of liquid biomarkers that can be isolated from body fluids, primarily blood14, 53. Moreover, liquid biopsies have turned out to be all the more clinically valuable in recent years due to the ability to pair tests on circulating tumor cells (CTCs), circulating tumor nucleic acids (ctNAs) and tumor derived exosomes with genomic tests53-56. (Figure 1A) Interestingly, liquid biopsy can characterize tumor biomarkers, similar to tissue biopsy which allows early detection of disease,
Pancreatic cancer is ready for investigation with a liquid biopsy, as indicated by analysts at The University of Texas MD Anderson Cancer Center52. A liquid biopsy is the simple, cheaper and faster, minimally invasive sampling and analysis of liquid biomarkers that can be isolated from body fluids, primarily blood14, 53. Moreover, liquid biopsies have turned out to be all the more clinically valuable in recent years due to the ability to pair tests on circulating tumor cells (CTCs), circulating tumor nucleic acids (ctNAs) and tumor derived exosomes with genomic tests53-56. (Figure 1A) Interestingly, liquid biopsy can characterize tumor biomarkers, similar to tissue biopsy which allows early detection of disease,